Concord Biotech Market Cap

Concord Biotech has a market cap or net worth of 219.66 billion as of June 10, 2025. Its market cap has increased by 43.81% in one year.

Market Cap

219.66B

Enterprise Value

216.52B

Revenue

12.00B

Ranking

n/a

PE Ratio

59.11

Stock Price

2,099.70

Market Cap Chart

Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 219.66B, an increase of 122.71%. That is a compound annual growth rate of 55.50%.

Market Cap History

Date	Market Cap	% Change
Jun 10, 2025	219.66B	-5.02%
Dec 31, 2024	231.28B	50.21%
Dec 29, 2023	153.97B	56.11%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sun Pharmaceutical Industries	4,028.96B
Divi's Laboratories	1,737.36B
Cipla	1,214.93B
Apollo Hospitals Enterprise	998.22B
Mankind Pharma	970.77B
Zydus Lifesciences	966.14B
Aurobindo Pharma	674.37B
Alkem Laboratories	581.38B

Market Cap Rankings